W. Ann Reynolds

Between 2008 and 2012 she made
$1,519,294
as a director, more than 77% of all directors

Paid CEOs an average of
$16,435,572
in the last year of her directorship, more than 57% of all directors

Decreased CEO pay by an average of
$283,829
between 2008 and 2012, only 31% of directors decreased pay more

Shares of her companies increased by
31.8%
between 2008 and 2012, better performance than 85% of all directors

The W. Ann Reynolds Stock Index

From January 2008 to April 2011, if you bought shares in companies when W. Ann Reynolds joined the board, and sold them when she left, you would have a 31.8 percent return on your investment, compared to a -8.9 percent return from the S&P 500.

W. Ann Reynolds's companies

Humana

Jan. 1, 1991 to April 21, 2011

Other board members at Humana during this time were David A. Jones, Jr., David B. Nash, M.D., Frank A. D’Amelio and 7 more.

Her Yearly Compensation

Yearly Payments to CEOs

MEDIAN

Abbott Laboratories

Jan. 1, 1980 to Jan. 1, 2010

Other board members at Abbott Laboratories during this time were David Owen, Glenn F. Tilton, H. L. Fuller and 9 more.

Stock Performance is the difference between a director's stock index and the S&P 500.
A director's stock index is an unweighted index of company stock performances while they sat on the board.
CEO pay includes salary, bonuses, stock sales, and other payments.
Average CEO Pay is calculated using the last year a director sat on the board of each company.
Stock returns do not include dividends.
All directors refers to people who sat on the board of at least one Fortune 100 company between 2008 and 2012.

The Pay Pals project relies on financial research conducted by the Center for Economic Policy and Research.

Sources: Google Finance, Yahoo Finance, Humana SEC filings (2008, 2009, 2010, 2011).

By Shane Shifflett, Jay Boice, Hilary Fung and Aaron Bycoffe